UPDATE 3-AbbVie spotlights Allergan deal, new drugs as Humira sales wane
July 26, 2019 at 13:25 PM EDT
AbbVie Inc said on Friday a combination of new drugs in its arsenal and its planned $63 billion deal for Botox-maker Allergan Plc will counter declining sales of its long-time bestseller, Humira.